Furthermore, we demonstrated that low BDNF and high vWF levels predicted adverse cardiovascular events at a12-month follow-up in patients with CAD, which is consistent with previous reports [9, 21, 37–40]. The gene discussed is VWF; the disease is coronary artery disorder.